Moore Capital Management’s Oculis Holding AG Warrants OCSAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$100K Sell
20,000
-21,666
-52% -$254K ﹤0.01% 595
2026
Q1
$542K Hold
41,666
0.01% 411
2025
Q4
$357K Hold
41,666
0.01% 511
2025
Q3
$282K Hold
41,666
﹤0.01% 500
2025
Q2
$369K Hold
41,666
﹤0.01% 435
2025
Q1
$312K Hold
41,666
0.01% 380
2024
Q4
$225K Hold
41,666
﹤0.01% 439
2024
Q3
$95.8K Hold
41,666
﹤0.01% 397
2024
Q2
$77.1K Hold
41,666
﹤0.01% 382
2024
Q1
$122K Hold
41,666
﹤0.01% 360
2023
Q4
$62.5K Hold
41,666
﹤0.01% 346
2023
Q3
$67.9K Hold
41,666
﹤0.01% 393
2023
Q2
$45.8K Hold
41,666
﹤0.01% 408
2023
Q1
$14K Buy
+41,666
New +$17.2K ﹤0.01% 418

Other funds holding OCSAW

Moore Capital Management's OCSAW Position: Q2 2026 in Review

Moore Capital Management reduced its Oculis Holding AG Warrants (OCSAW) stake by 52% in Q2 2026, selling an estimated $254K and leaving 20,000 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #595.

Moore Capital Management first reported a position in OCSAW in Q1 2023 and has held it in 14 quarters since. The position peaked at $542K in Q1 2026. 8 funds tracked by Wall St. Rank hold OCSAW as of Q2 2026.

  • Moore Capital Management held 20,000 shares of Oculis Holding AG Warrants worth $100K as of Q2 2026.
  • Moore Capital Management sold 21,666 Oculis Holding AG Warrants shares in Q2 2026, an estimated $254K.
  • Oculis Holding AG Warrants made up ﹤0.01% of Moore Capital Management's portfolio in Q2 2026, its #595 holding.
  • Moore Capital Management first reported a position in Oculis Holding AG Warrants in Q1 2023 and has held it in 14 quarters since.
  • Moore Capital Management's Oculis Holding AG Warrants position peaked at $542K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Oculis Holding AG Warrants as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.